Martin J. Driscoll, President and CEO at Spring Bank Pharmaceuticals, Inc. (SBPH), bought 2,000 shares at $9.77 ($20K) on 2016-08-04, disclosed to the SEC on 2016-08-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.77 | 1,000 | $10K | 49.0% |
| 2 | $10.15 | 1,000 | $10K | 51.0% |
| Total | $9.96 avg | 2,000 | $20K | 100% |
| Filing → |
| SBPH | BUY | 2019-05-29 | $60K | — | Filing → |
| SBPH | BUY | 2019-05-22 | $33K | — | Filing → |
| SBPH | BUY | 2019-04-30 | $73K | — | Filing → |